Company: CRLBF
Filing Date: 2025-08-20
Form Type: SC TO-C
Source: 0001832928-25-000020
Chunk: 1

Company: Cresco Labs Inc.
Filing Date: 2025-08-20
Form: SC TO-C
Chunk 1
---
 will be given the opportunity to exchange certain outstanding options to purchase the Company’s subordinate voting shares for new restricted stock units vesting ratably over three years.

On August 19, 2025, the Company distributed to Eligible Participants an introductory email from its Chief Executive Officer and accompanying Frequently Asked Questions regarding the Exchange Offer. Copies of those communications are included as Exhibits 99.1 and 99.2 hereto and are being filed as pre-commencement communications pursuant to Rule 14d-2(b) of the Securities Exchange Act of 1934, as amended. These communications did not provide instructions for tendering and were for informational purposes only. The Exchange Offer will be made upon the terms and subject to the conditions set forth in an Offer to Exchange Eligible Options for New Awards (“

#### Offer to Exchange
”), including receipt of shareholder approval of the Exchange Offer at the Company’s annual general and special meeting to be held on September 16, 2025. The Company expects to file a Schedule TO, including the Offer to Exchange and other offer materials, to commence the Exchange Offer on or about August 20, 2025.

This filing does not constitute an offer to holders of the Company’s outstanding stock options to exchange those options. The Exchange Offer has not yet commenced and the Company may decide not to implement the Exchange Offer. If the Company decides to implement the Exchange Offer, the terms and conditions of the Exchange Offer will be set forth in a Tender Offer Statement on Schedule TO, including an Offer to Exchange and other related materials.

The Company will file the Tender Offer Statement on Schedule TO with the Securities and Exchange Commission (the “SEC”) if and when the Exchange Offer program commences. Eligible Participants should read the Tender Offer Statement on Schedule TO and other related materials, including the Offer to Exchange and the other material referenced therein, if and when those materials become available, because they will contain important information about the Company and the Exchange Offer.

The Company’s shareholders and option holders will be able to obtain the written materials described above and the other documents filed by the Company with the SEC free of charge from the SEC’s website at www.sec.gov or by directing a written request to: Cresco Labs Inc., 600 West Fulton Street, Suite 800, Chicago, IL 60661.

Forward-Looking Statements

This Schedule contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions